That's what I was going to say, the meeting is too far out to be bad news from the two meetings this week. A bad news CC would have had to have been on Monday for the FDA BLA meeting or Tuesday for the UK MHRA meeting. Is CytoDyn telegraphing that the CC is not about bad news by ensuring the CC is more than 4 business days after the two regulatory meetings? Maybe this is very very good news, we just need to get the details worked out a few more days with the FDA and/or the MHRA.